These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25070686)

  • 1. (177)Lu-EDTMP for palliation of pain from bone metastases in patients with prostate and breast cancer: a phase II study.
    Agarwal KK; Singla S; Arora G; Bal C
    Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):79-88. PubMed ID: 25070686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of 177Lu-EDTMP in bone metastatic pain palliation in breast cancer and hormone refractory prostate cancer: a phase II study.
    Yuan J; Liu C; Liu X; Wang Y; Kuai D; Zhang G; Zaknun JJ
    Clin Nucl Med; 2013 Feb; 38(2):88-92. PubMed ID: 23334120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Efficacy and Safety Comparison of 177Lu-EDTMP with 153Sm-EDTMP on an Equidose Basis in Patients with Painful Skeletal Metastases.
    Thapa P; Nikam D; Das T; Sonawane G; Agarwal JP; Basu S
    J Nucl Med; 2015 Oct; 56(10):1513-9. PubMed ID: 26315829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic, Dosimetry and Toxicity Study of ¹⁷⁷Lu-EDTMP in Patients: Phase 0/I study.
    Bal C; Arora G; Kumar P; Damle N; Das T; Chakraborty S; Banerjee S; Venkatesh M; Zaknun JJ; Pillai MR
    Curr Radiopharm; 2016; 9(1):71-84. PubMed ID: 25771371
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Askari E; Harsini S; Vahidfar N; Divband G; Sadeghi R
    Cancer Biother Radiopharm; 2021 Jun; 36(5):383-390. PubMed ID: 33259726
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and toxicity of 153samarium-EDTMP in painful breast cancer bone metastases.
    Dolezal J
    Onkologie; 2009 Feb; 32(1-2):35-9. PubMed ID: 19209017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 89Sr versus 153Sm-EDTMP: comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma.
    Baczyk M; Czepczyński R; Milecki P; Pisarek M; Oleksa R; Sowiński J
    Nucl Med Commun; 2007 Apr; 28(4):245-50. PubMed ID: 17325585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ¹⁷⁷Lu-EDTMP for treatment of bone pain in patients with disseminated skeletal metastases.
    Shinto AS; Shibu D; Kamaleshwaran KK; Das T; Chakraborty S; Banerjee S; Thirumalaisamy P; Das P; Veersekar G
    J Nucl Med Technol; 2014 Mar; 42(1):55-61. PubMed ID: 24503346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases.
    Liepe K; Kotzerke J
    Nucl Med Commun; 2007 Aug; 28(8):623-30. PubMed ID: 17625384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (153)Sm-EDTMP for pain relief of bone metastases from prostate and breast cancer and other malignancies.
    Correa-González L; Arteaga de Murphy C; Pichardo-Romero P; Pedraza-López M; Moreno-García C; Correa-Hernández L
    Arch Med Res; 2014 May; 45(4):301-8. PubMed ID: 24681187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myelotoxicity after systemic radionuclide therapy of painful bone metastases with 153Samarium-EDTMP ].
    Dolezal J; Vizd'a J; Cermáková E
    Vnitr Lek; 2003 Mar; 49(3):189-93. PubMed ID: 12728593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain.
    Liepe K; Runge R; Kotzerke J
    J Cancer Res Clin Oncol; 2005 Jan; 131(1):60-6. PubMed ID: 15449184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of samarium-153-EDTMP radionuclide treatment for bone metastases in patients with hormone-refractory prostate cancer.
    Dolezal J; Vizda J; Odrazka K
    Urol Int; 2007; 78(1):50-7. PubMed ID: 17192733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An automated synthesis of 177Lu-EDTMP as an efficient bone-seeking therapeutic radiopharmaceutical.
    Elboga U; Kilbas B; Sahin E; Cayırlı YB; Eryilmaz K; Begec T; Bakar HE; Mercanoglu G; Celen YZ
    Eur Rev Med Pharmacol Sci; 2021 Jul; 25(14):4829-4834. PubMed ID: 34337731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of organ-specific dose and lesional doses following therapeutic [177Lu]Lu-EDTMP administration in patients with multiple skeletal metastases and its correlation with clinical hematological toxicity.
    Kamaldeep ; Thapa P; Wanage G; Tervankar S; Kaisar S; Ranade R; Basu S; Das T; Banerjee S
    Nucl Med Commun; 2021 Oct; 42(10):1076-1084. PubMed ID: 34528928
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Alavi M; Khajeh-Rahimi F; Yousefnia H; Mohammadianpanah M; Zolghadri S; Bahrami-Samani A; Ghannadi-Maragheh M
    Cancer Biother Radiopharm; 2019 Jun; 34(5):280-287. PubMed ID: 30977670
    [No Abstract]   [Full Text] [Related]  

  • 17. 153Sm-EDTMP for bone pain palliation in skeletal metastases.
    Maini CL; Bergomi S; Romano L; Sciuto R
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S171-8. PubMed ID: 15127241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the dose-myelotoxicity correlation in radiometabolic therapy of bone metastases with 153Sm-EDTMP.
    Pacilio M; Ventroni G; Basile C; Ialongo P; Becci D; Mango L
    Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):238-52. PubMed ID: 24077786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical benefit of bone-targeted radiometabolic therapy with 153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer.
    Ricci S; Boni G; Pastina I; Genovesi D; Cianci C; Chiacchio S; Orlandini C; Grosso M; Alsharif A; Chioni A; Di Donato S; Francesca F; Selli C; Rubello D; Mariani G
    Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):1023-30. PubMed ID: 17242920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial.
    Collins C; Eary JF; Donaldson G; Vernon C; Bush NE; Petersdorf S; Livingston RB; Gordon EE; Chapman CR; Appelbaum FR
    J Nucl Med; 1993 Nov; 34(11):1839-44. PubMed ID: 8229221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.